Olga Novikov-King, MD PhD

Dr. Olga Novikov-King is a board-certified psychiatrist who has been practicing in Massachusetts since 2018. After immigrating to the United States at 13, she studied at Boston University for her medical education while simultaneously pursuing her PhD in Molecular Medicine. Following medical school, Dr. Novikov-King completed her residency in adult psychiatry at Boston Medical Center. Since residency, Dr. Novikov-King has practiced as a consult-liaison psychiatrist at South Shore Hospital, and directed St. Vincent Medical Center's inpatient psychiatry ward. Dr. Novikov-King is passionate about innovative ways of approaching mental health and well-being, including nutritional psychiatry, lifestyle psychiatry, and avant-garde medicinal approaches.

 Outside of medicine, Dr. Novikov-King enjoys the simple things in life, physical fitness, playing piano, cooking, spending time with her family, and traveling.

 Dr. Novikov-King cares for patients residing in CA and MA aged 18-64 at Joie Mental Health.

More Information

    • Undergraduate: BA in Biochemistry and Molecular Biology with a Minor in Mathematics from Boston University

    • Medical School: MD from Boston University

    • Graduate School: Master of Arts in Medical Science + PhD in Molecular Medicine from Boston University

    • Medical Residency: Adult Psychiatry from Boston University/ Boston Medical Center

  • Rasmusson A.M, Novikov O, Brown K.D., Pinna G;, Pineles S.L. Pleiotropic endophenotypic and phenotype effects of GABAergic neurosteroid synthesis deficiency in posttraumatic stress disorder. Current Opinion in Endocrine and Metabolic Research. 2022, Aug; 25: ISSN 2451-9650

    Novikov O, Wang Z, Stanford EA, Parks AJ, Ramirez-Cardenas A, Landesman E, Laklouk I, Sarita-Reyes C, Gusenleitner D, Li A, Monti S, Manteiga S, Lee K, Sherr DH.. An Aryl Hydrocarbon Receptor-Mediated Amplification Loop That Enforces Cell Migration in ER-/PR-/Her2- Human Breast Cancer Cells. Molecular Pharmacology. 2016, Nov; 90(5): 674-688.

    Stanford EA, Wang Z, Novikov O, Mulas F, Landesman-Bollag E, Monti S, Smith BW, Seldin DC, Murphy GJ, Sherr DH. The Role of the Aryl Hydrocarbon Receptor in the Development of Cells with the Molecular and Functional Characteristics of Cancer Stem-Like Cells. BMC Biology. 2016, Mar; 14(1): 20

    Narashiman S, Stanford Zulick E, Novikov O, Parks AJ, Schlezinger JJ, Wang Z, Laroche F, Feng H, Mulas F, Monti S, Sherr DH, Towards Resolving the Pro- and Anti-Tumor Effects of the Aryl Hydrocarbon Receptor. Int J Mol Sci. 2018, May 7;19(5):1388

    Parks, A., Pollastri, M., Hahn, M., Stanford, E., Novikov, O., Franks, D., Haigh S., Narasimhan, S., Ashton, T.,Hopper, T., Kozakov, D., Beglov, D., Vajda, S., Schlezinger, J., Sherr, D. In Silico Identification of an Aryl Hydrocarbon Receptor (AHR) Antagonist with Biological Activity In Vitro and In Vivo. Molecular Pharmacology. 2014, Nov; 86(5): 593–608.

    Stanford EA, Ramirez-Cardenas A, Wang Z, Novikov O, Alamoud K, Koutrakis P, Mizgerd JP, Genco CA, Kukuruzinska M, Monti S, Bais MV, Sherr DH.. Role for the Aryl Hydrocarbon Receptor and Diverse Ligands in Oral Squamous Cell Carcinoma Migration and Tumorigenesis. Molecular Cancer Research. 2016, Aug; 14(8): 696-706.

    Wang Z, Snyder M, Kenison JE, Yang K, Lara B, Lydell E, Bennani K, Novikov O, Federico A, Monti S, Sherr DH. How the AHR Became Important in Cancer: The Role of Chronically Active AHR in Cancer Aggression. Int J Mol Sci. 2020 Dec 31;22(1):387

    • American Psychiatric Association

    • Massachusetts Medical Society

    • European-American, “third culture”, cross-cultural mental health

    • Women’s Mental Health

    • Intersection of Medical Conditions and Mental Illness